Reports Q1 revenue $13.4M, consensus $13.16M. “We delivered a strong start to 2026, achieving 14% revenue growth and meaningful margin expansion,” said Kevin J. Knopp, CEO and Co-founder. “We are also excited to announce the acquisition of NIRLAB AG, a strategic transaction that broadens our reach into the lower-cost, widely-deployable segment of the narcotics detection market while increasing our recurring revenue opportunity through software subscriptions. This transaction reflects our focus on disciplined growth investments as we continue to execute our transformation strategy.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASS:
- 908 Devices Completes NIRLAB Acquisition, Advances Growth Strategy
- 908 Devices names Kola Otitoju as Chief Business & Strategy Officer
- 908 Devices’ Smaller-Reporting Status May Curb Transparency, Weigh on Investor Appeal and Volatility
- 908 Devices files $100M mixed securities shelf
- 908 Devices Earnings Call Signals Gradual Turnaround